activity 100-to 400-fold (Kubo, Castro-Curel, Ibanez, Glass, and Code, 1964; Fiasse, Kubo, Code, and Glass, 1966; Glass, Code, Kubo, and Fiasse, 1967; Glass, 1968) .
Possible relationships between the parietal cell antibodies and gastrone have not been explored. As a preliminary, the inhibitory activity of some globulin fractions from pernicious-anaemia sera was tested on pyloric secretion in rats (Glass, 1965) . Some of the fractions separated on columns of DEAE-Sephadex A-50 and of Sephadex G-200 'This investigation was supported in part by research grants AM-00068, AM-04391, CA-08251, AM-09701, and training grant AM-05237 from the National Institutes of Health, US Public Health Service.
were slightly inhibitory, but the results were not clear cut, since some fractions from normal sera inhibited the gastric secretion of acid in rats with pyloric ligation.
This study was undertaken to test the validity of those preliminary observations and to extend them by determining what effects on gastric secretion are produced by purified immunoglobulins from sera with and without parietal cell antibodies in acute experiments.
The well established cross-reactivity between the human parietal cell antibodies and the parietal cells of rats (Jeffries and Sleisenger, 1965; De Boer, Nairn, and Maxwell, 1965) causes human parietal cell antibody to react with the antigen of the rat parietal cells. Also, the inhibitory activity of gastrone may be assayed well in the rat stomach with the pylorus ligated (Menguy and Smith, 1959; Code, 1967) . For these reasons, we studied the effect of human parietal cell antibodies on gastric secretion in the rat stomach.
MATERIAL AND METHODS
SERA AND THEIR SOURCES Sera were obtained from 21 patients, of whom 12 had atrophic gastritis and four of these had pernicious anaemia. Ten patients had parietal cell antibodies in their sera and 11 did not. The latter included four with peptic ulcers, two with gastric cancers, two with subtotal gastrectomies, one with portal cirrhosis, one with atrophic gastritis, and one with pernicious anaemia. Of the lOwith parietal cell antibodies, seven had atrophic gastritis, one hypothyroidism, one primary biliary cirrhosis, and one Wilson's disease. In the latter three cases, the presence of circulating parietal cell antibodies was related to the underlying hepatic (Mackay, 1964) or thyroid disease (Doniach and Roitt, 1964) .
The four patients with pernicious anaemia also had circulating blocking intrinsic factor antibodies in their sera.
After collection, the sera were stored separately at-20°C. 39
Before fractionation, each was thawed and dialyzed against 0-01M phosphate buffer of pH 7.55. IgG was separated from the serum by the method of Vaerman, Heremans, and Vaerman (1963) . After dialysis and centrifugation at 2,000 rpm, the precipitate was discarded and 1 to 2 ml of the supernatant was applied to the top of a column (2 by 8 cm) that had been packed with DEAE cellulose Serva and washed thoroughly with the buffer used in dialysis. The column then was eluted in a cold room with the same buffer at a flow rate of 6 ml/hr. The effluent was collected in 2-ml fractions by means of a linear fraction collector provided with a volumetric counting unit. The optical density of each fraction was read at 280 m,u in a DB Beckman spectrophotometer, and a graph was made to show the optical densities of all the fractions of the effluent from each serum. Since the first sharp peak of optical density is known to correspond to IgG (Vaerman et al, 1963) , the fractions corresponding to this peak were then pooled, dialyzed overnight against running tap water, and lyophilized.
IMMUNOELECTROPHORESIS The purity of the IgG material obtained by this fractionation was tested by immunoelectrophoresis against antiserum to human serum. One gl of a 2% solution of this material in veronal-acetate buffer, of pH 8.6 and ionic strength 0.05, was put into one well of an agar plate, the other being filled with normal human serum; and both were subjected to electrophoresis with the modified Scheidegger (1955) method. Subsequently, the trough was filled with horse antiserum to human serum (Hyland) and the plate was incubated in a moist chamber for several days. After development of the precipitin lines, the plates were dried and stained with thiazine red.
ASSAYS FOR PARIETAL CELL ANTIBODIES Each serum and
IgG fraction processed from it were tested for parietal cell antibodies by the modification by Taylor et al (1962) of the indirect technique of Coons. Quick-frozen specimens of normal mucosa from the human gastric fundus were cut in a cryostat to a thickness of 6 t,u and these sections were placed on microscope slides and fixed under dry air at room temperature. The slides were incubated for 20 minutes with the undiluted serum to be tested, and also with a 1 % solution of saline of the lyophilized IgG separated from the same serum. Control slides were incubated with normal sera (not containing parietal cell antibodies). Then the slides were washed for 10 minutes in two changes of Coons' buffer. After blotting of excess fluid (except close to the section) they were incubated with one drop of fluorescinated rabbit antiserum to IgG (Hyland), washed three times in Coons' buffer, and (after blotting of the excess of buffer) mounted in 50 % buffered glycerine of pH 8-0. After this, the preparations were covered with cover slips, sealed with colourless nailpolish, and viewed under a Leitz fluorescent microscope provided with an Osram UV high-pressure vapour lamp.
ASSAYS FOR INTRINSIC FACTOR ANTIBODIES Assay for blocking intrinsic-factor antibodies was performed by the modified (Yamaguchi and Glass, 1967) method of Ardeman and Chanarin (1963) and Gottlieb, Lau, Wasserman, and Herbert (1965) , using whole intrinsic factor inhibitory sera.
ASSAY FOR INHIBITOR OF GASTRIC SECRETION Each of the IgG samples processed on the column was sent from New York to Rochester, Minnesota, for assay of its power to inhibit gastric secretion in rats. This was done in a blind study by a method described before (Code, 1967) . Rats weighing 270 to 340 g were fasted for 48 hours. Under light ether anaesthesia, the pylorus was ligated, the test material was injected intravenously in doses varying from 10 to 5,000 gg, and the rats were returned to cages designed to avoid coprophagy. After five hours, they were reanaesthetized, the cardia was ligated, and the stomachs were removed. The volume of juice in the stomach was measured, and its HCI content determined by an electrometric autotitrator with an endpoint of pH 7.0. The output of acid was calculated from the acid concentration and volume of gastric juice.
The fractions of IgG were given in at least three different doses to groups of three or four rats, while one group of three or four rats was given saline solution as control. From the results, a semilogarithmic doseresponse plot was made; and the quantity producing 50% inhibition was interpolated.
RESULTS
The chromatograms of the sera fractionated on the DEAE cellulose column are typified by Figure 1 . A sharp peak of optical density, followed by some trailing, was obtained in each of the sera examined. When subjected to immunoelectrophoresis against the antiserum to human serum, the material contained in the sharp peak proved to be IgG. It always showed one precipitin line to IgG, which was similar to the IgG line obtained with normal serum (Fig. 2) .
The 21 sera and the IgG fractions separated from them on the column were assayed for parietal cell antibody activity. Parietal-cell antibodies were present in IgG fractions of sera containing these antibodies and not in others. The parietal cell anti- bodies contained in the sera and in the IgG fractions gave positive fluorescence by the indirect method of Coons both with normal human and with rat gastric mucosa (Figs. 3 and 4) . The inhibitory activity of all the IgG fractions processed from the 21 sera was tested on rats with pyloric ligation (Table I) . Seventeen of the 21 IgG fractions produced no significant inhibition in doses ranging from 10 to 1,000 ,ug ( Fig. 5 and Table I ).
Slight or questionable inhibitory activity was shown by four IgG fractions at levels of 50 to 1,000 gg, but only one (no. 10) provided a satisfactory doseresponse curve. Furthermore, three of the four sera showing slight or questionable inhibitory activity did not contain parietal cell (Table II) from parietal cell antibodies containing sera was raised up to 5 mg (Table III) . 
COMMENT
After fractionation of sera containing parietal cell antibody it appeared in the IgG fraction. Yet this fraction, when injected intravenously into rats with pyloric ligation, did not inhibit gastric secretion, at least during the five-hour testing period, up to a dose of 10 mg. This is in contrast to the potent inhibitory effect of gastrone fractions separated from anacid gastric juice and tested under similar conditions, for they produce 50% inhibition in doses of 17 to 40 ,ug (mean 22) (Fiasse, Code, and Glass, 1968) . The lack of inhibitory activity of IgG upon gastric secretion in the rat cannot be due to a lack of the cross reactivity, for, as mentioned before, the cross reactivity between parietal cell antibody of Apparently, there is no significant relationship between gastrone, the endogenous inhibitor of gastric secretion, which is derived from human anacid gastric juice, and the IgG and parietal cell antibody from the serum of patients with gastric anacidity.
The limitations of our study are appreciated. To ascertain the function of parietal cell antibody in the production of gastric atrophy and anacidity will require more protracted investigation in which the effect of prolonged exposure of the gastric mucosa to parietal cell antibody is tested. This work is now in progress (Tanaka and Glass, unpublished These findings were obtained in an acute experiment and do not rule out a possible long-term effect of prolonged exposure of parietal cells to circulating parietal cell antibodies.
Dr Howard Siegel, of the Gastroenterology Section of the New York Medical College, performed the gastric suction biopsies; Dr Nobuo Yamaguchi, from the same group, determined the presence of intrinsic factor antibodies; and Miss Rita Gottschalk gave valuable technical assistance.
